Evidence map›Paper›PMID 42761558›Full record

Observational studyJournal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques2026

Age-related risk factors for leftover drugs: a lifespan analysis in community pharmacies.

Toshiyuki Hirai, Shunsuke Hanaoka, Yuusuke Terakado, Toshiichi Seki, Hiroyuki Hayashi, Fumiyuki Watanabe

Abstract readObservational Study
In one paragraph

Observational study in Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Toshiyuki HiraiDepartment of Pharmacy, Hitachi, Ltd. Hitachinaka General Hospital, Ibaraki, Japan.
Shunsuke HanaokaLaboratory of Pharmacotherapy, School of Pharmacy, Nihon University, Chiba, Japan.
Yuusuke TerakadoDepartment of Pharmacy, Hitachi, Ltd. Hitachinaka General Hospital, Ibaraki, Japan.
Toshiichi SekiDepartment of Pharmacy, Hitachi, Ltd. Hitachinaka General Hospital, Ibaraki, Japan.
Hiroyuki HayashiLaboratory of Pharmacotherapy, School of Pharmacy, Nihon University, Chiba, Japan.
Fumiyuki WatanabeLaboratory of Pharmacy Practice in Primary Care, School of Pharmacy, Nihon University, Chiba, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Medication adherence is a critical global challenge because suboptimal adherence reduces therapeutic efficacy and increases healthcare costs. While leftover drugs are vital indicators of potential adherence-related challenges, age-specific factors contributing to their occurrence, particularly across the lifespan, remain insufficiently understood. This study was aimed at clarifying age-stratified factors associated with leftover drugs using large-scale objective data from protocol-based pharmacotherapy management (PBPM) in community pharmacies. Methods: This was a single-center, retrospective, observational cohort study of 36,340 outpatients. Objective reporting of data based on the PBPM in community pharmacies between 2016 and 2021 was analyzed. Multivariate logistic regression and predicted probability models were used to evaluate the interactions between age (decade-stratified) and four primary clinical factors: drug count, prescription duration, prescribing department count, and sex. Results: The overall proportion of leftover drugs was 9.6% ( Conclusion: This study highlights the influence of clinical characteristics on leftover drug shifting substantially with age. Consequently, effective management requires age-specific interventions centered on minimizing drug counts, with an emphasis on optimizing prescription duration in younger adults and promoting medication simplification and inter-institutional coordination in older adults.

Indexed as

Community Pharmacy ServicesPharmaciesAdolescentAdultAgedAged, 80 and overAge FactorsFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsYoung Adultage-specific factorscommunity pharmacyleftover drugsmedication adherencepolypharmacy

Identifiers

PMID42761558
PMCPMC13586776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.